(Q34471993)

2 August 2017

1 reference

title

MRSA patients: proven methods to treat colonization and infection (English)

1 reference

2 August 2017

0 references

Boyce JM

1

1 reference

2 August 2017

publication date

1 August 2001

1 reference

Journal of Hospital Infection

2 August 2017

published in

1 reference

2 August 2017

volume

48 Suppl A

1 reference

2 August 2017

page(s)

S9-14

1 reference

A new technique for the control of hospital cross-infection. Experience with BRL. 1241 in a maternity unit

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

A laboratory-confirmed outbreak of rifampicin-methicillin resistant Staphylococcus aureus (RMRSA) in a newborn nursery

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Mediastinitis following coronary artery bypass surgery: a 3-year review

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

A cloud adult: the Staphylococcus aureus-virus interaction revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

New threats to the control of methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: efficacy of mupirocin ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

The management of methicillin-resistant Staphylococcus aureus in a major hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2801%2990005-2

7 January 2021

10.1016/S0195-6701(01)90005-2

Identifiers

DOI

1 reference

2 August 2017

1 reference